According to WiseGuyReports, the β-Nicotinamide Mononucleotide Market is projected to expand from USD 1.2 billion in 2025 to USD 5.0 billion by 2035, registering a compound annual growth rate (CAGR) of 15.5% during the 2026–2035 forecast period. The market was valued at USD 1,000 million in 2024. Growing interest in anti-aging products, increasing awareness of health...
